Allergan Settles Apotex Pinkeye Meds Product-Hopping Suit
A Delaware federal judge on Wednesday dismissed a 5-year-old lawsuit alleging Allergan Inc. conspired with other pharmaceutical companies to stifle competition for its Zymar pinkeye treatment after the company announced it...To view the full article, register now.
Already a subscriber? Click here to view full article